Click for best price
Pediatric ADHD Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Pediatric ADHD Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric ADHD Drugs. This report contains market size and forecasts of Pediatric ADHD Drugs in global, including the following market information:
Global Pediatric ADHD Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pediatric ADHD Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pediatric ADHD Drugs include Pfizer, Johnson & Johnson, Eli Lilly and Company, Tris Pharma, Noven Pharmaceuticals, Alcobra Pharmaceuticals, Novartis, GlaxoSmithKline and Purdue Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pediatric ADHD Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric ADHD Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pediatric ADHD Drugs Market Segment Percentages, by Type, 2022 (%)
Tablets
Oral Liquid
Other
Global Pediatric ADHD Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pediatric ADHD Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Pediatric ADHD Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pediatric ADHD Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric ADHD Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pediatric ADHD Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Eli Lilly and Company
Tris Pharma
Noven Pharmaceuticals
Alcobra Pharmaceuticals
Novartis
GlaxoSmithKline
Purdue Pharma
Takeda Pharmaceutical
Curemark
Supernus Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pediatric ADHD Drugs, market overview.
Chapter 2: Global Pediatric ADHD Drugs market size in revenue.
Chapter 3: Detailed analysis of Pediatric ADHD Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pediatric ADHD Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pediatric ADHD Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pediatric ADHD Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric ADHD Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatric ADHD Drugs Overall Market Size
2.1 Global Pediatric ADHD Drugs Market Size: 2022 VS 2029
2.2 Global Pediatric ADHD Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pediatric ADHD Drugs Players in Global Market
3.2 Top Global Pediatric ADHD Drugs Companies Ranked by Revenue
3.3 Global Pediatric ADHD Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pediatric ADHD Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pediatric ADHD Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric ADHD Drugs Players in Global Market
3.6.1 List of Global Tier 1 Pediatric ADHD Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Pediatric ADHD Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pediatric ADHD Drugs Market Size Markets, 2022 & 2029
4.1.2 Tablets
4.1.3 Oral Liquid
4.1.4 Other
4.2 By Type - Global Pediatric ADHD Drugs Revenue & Forecasts
4.2.1 By Type - Global Pediatric ADHD Drugs Revenue, 2018-2023
4.2.2 By Type - Global Pediatric ADHD Drugs Revenue, 2024-2029
4.2.3 By Type - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pediatric ADHD Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Pediatric ADHD Drugs Revenue & Forecasts
5.2.1 By Application - Global Pediatric ADHD Drugs Revenue, 2018-2023
5.2.2 By Application - Global Pediatric ADHD Drugs Revenue, 2024-2029
5.2.3 By Application - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pediatric ADHD Drugs Market Size, 2022 & 2029
6.2 By Region - Global Pediatric ADHD Drugs Revenue & Forecasts
6.2.1 By Region - Global Pediatric ADHD Drugs Revenue, 2018-2023
6.2.2 By Region - Global Pediatric ADHD Drugs Revenue, 2024-2029
6.2.3 By Region - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pediatric ADHD Drugs Revenue, 2018-2029
6.3.2 US Pediatric ADHD Drugs Market Size, 2018-2029
6.3.3 Canada Pediatric ADHD Drugs Market Size, 2018-2029
6.3.4 Mexico Pediatric ADHD Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pediatric ADHD Drugs Revenue, 2018-2029
6.4.2 Germany Pediatric ADHD Drugs Market Size, 2018-2029
6.4.3 France Pediatric ADHD Drugs Market Size, 2018-2029
6.4.4 U.K. Pediatric ADHD Drugs Market Size, 2018-2029
6.4.5 Italy Pediatric ADHD Drugs Market Size, 2018-2029
6.4.6 Russia Pediatric ADHD Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Pediatric ADHD Drugs Market Size, 2018-2029
6.4.8 Benelux Pediatric ADHD Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pediatric ADHD Drugs Revenue, 2018-2029
6.5.2 China Pediatric ADHD Drugs Market Size, 2018-2029
6.5.3 Japan Pediatric ADHD Drugs Market Size, 2018-2029
6.5.4 South Korea Pediatric ADHD Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Pediatric ADHD Drugs Market Size, 2018-2029
6.5.6 India Pediatric ADHD Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pediatric ADHD Drugs Revenue, 2018-2029
6.6.2 Brazil Pediatric ADHD Drugs Market Size, 2018-2029
6.6.3 Argentina Pediatric ADHD Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pediatric ADHD Drugs Revenue, 2018-2029
6.7.2 Turkey Pediatric ADHD Drugs Market Size, 2018-2029
6.7.3 Israel Pediatric ADHD Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Pediatric ADHD Drugs Market Size, 2018-2029
6.7.5 UAE Pediatric ADHD Drugs Market Size, 2018-2029
7 Pediatric ADHD Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pediatric ADHD Drugs Major Product Offerings
7.1.4 Pfizer Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Pediatric ADHD Drugs Major Product Offerings
7.2.4 Johnson & Johnson Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Company Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company Pediatric ADHD Drugs Major Product Offerings
7.3.4 Eli Lilly and Company Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly and Company Key News & Latest Developments
7.4 Tris Pharma
7.4.1 Tris Pharma Company Summary
7.4.2 Tris Pharma Business Overview
7.4.3 Tris Pharma Pediatric ADHD Drugs Major Product Offerings
7.4.4 Tris Pharma Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.4.5 Tris Pharma Key News & Latest Developments
7.5 Noven Pharmaceuticals
7.5.1 Noven Pharmaceuticals Company Summary
7.5.2 Noven Pharmaceuticals Business Overview
7.5.3 Noven Pharmaceuticals Pediatric ADHD Drugs Major Product Offerings
7.5.4 Noven Pharmaceuticals Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.5.5 Noven Pharmaceuticals Key News & Latest Developments
7.6 Alcobra Pharmaceuticals
7.6.1 Alcobra Pharmaceuticals Company Summary
7.6.2 Alcobra Pharmaceuticals Business Overview
7.6.3 Alcobra Pharmaceuticals Pediatric ADHD Drugs Major Product Offerings
7.6.4 Alcobra Pharmaceuticals Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.6.5 Alcobra Pharmaceuticals Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Pediatric ADHD Drugs Major Product Offerings
7.7.4 Novartis Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Pediatric ADHD Drugs Major Product Offerings
7.8.4 GlaxoSmithKline Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Purdue Pharma
7.9.1 Purdue Pharma Company Summary
7.9.2 Purdue Pharma Business Overview
7.9.3 Purdue Pharma Pediatric ADHD Drugs Major Product Offerings
7.9.4 Purdue Pharma Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.9.5 Purdue Pharma Key News & Latest Developments
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Company Summary
7.10.2 Takeda Pharmaceutical Business Overview
7.10.3 Takeda Pharmaceutical Pediatric ADHD Drugs Major Product Offerings
7.10.4 Takeda Pharmaceutical Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.10.5 Takeda Pharmaceutical Key News & Latest Developments
7.11 Curemark
7.11.1 Curemark Company Summary
7.11.2 Curemark Business Overview
7.11.3 Curemark Pediatric ADHD Drugs Major Product Offerings
7.11.4 Curemark Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.11.5 Curemark Key News & Latest Developments
7.12 Supernus Pharmaceuticals
7.12.1 Supernus Pharmaceuticals Company Summary
7.12.2 Supernus Pharmaceuticals Business Overview
7.12.3 Supernus Pharmaceuticals Pediatric ADHD Drugs Major Product Offerings
7.12.4 Supernus Pharmaceuticals Pediatric ADHD Drugs Revenue in Global Market (2018-2023)
7.12.5 Supernus Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pediatric ADHD Drugs Market Opportunities & Trends in Global Market
Table 2. Pediatric ADHD Drugs Market Drivers in Global Market
Table 3. Pediatric ADHD Drugs Market Restraints in Global Market
Table 4. Key Players of Pediatric ADHD Drugs in Global Market
Table 5. Top Pediatric ADHD Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pediatric ADHD Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pediatric ADHD Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pediatric ADHD Drugs Product Type
Table 9. List of Global Tier 1 Pediatric ADHD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric ADHD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pediatric ADHD Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pediatric ADHD Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pediatric ADHD Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pediatric ADHD Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pediatric ADHD Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pediatric ADHD Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pediatric ADHD Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Pediatric ADHD Drugs Product Offerings
Table 32. Pfizer Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Pediatric ADHD Drugs Product Offerings
Table 36. Johnson & Johnson Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Eli Lilly and Company Company Summary
Table 39. Eli Lilly and Company Pediatric ADHD Drugs Product Offerings
Table 40. Eli Lilly and Company Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly and Company Key News & Latest Developments
Table 42. Tris Pharma Company Summary
Table 43. Tris Pharma Pediatric ADHD Drugs Product Offerings
Table 44. Tris Pharma Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Tris Pharma Key News & Latest Developments
Table 46. Noven Pharmaceuticals Company Summary
Table 47. Noven Pharmaceuticals Pediatric ADHD Drugs Product Offerings
Table 48. Noven Pharmaceuticals Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Noven Pharmaceuticals Key News & Latest Developments
Table 50. Alcobra Pharmaceuticals Company Summary
Table 51. Alcobra Pharmaceuticals Pediatric ADHD Drugs Product Offerings
Table 52. Alcobra Pharmaceuticals Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Alcobra Pharmaceuticals Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Pediatric ADHD Drugs Product Offerings
Table 56. Novartis Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Pediatric ADHD Drugs Product Offerings
Table 60. GlaxoSmithKline Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Purdue Pharma Company Summary
Table 63. Purdue Pharma Pediatric ADHD Drugs Product Offerings
Table 64. Purdue Pharma Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Purdue Pharma Key News & Latest Developments
Table 66. Takeda Pharmaceutical Company Summary
Table 67. Takeda Pharmaceutical Pediatric ADHD Drugs Product Offerings
Table 68. Takeda Pharmaceutical Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda Pharmaceutical Key News & Latest Developments
Table 70. Curemark Company Summary
Table 71. Curemark Pediatric ADHD Drugs Product Offerings
Table 72. Curemark Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Curemark Key News & Latest Developments
Table 74. Supernus Pharmaceuticals Company Summary
Table 75. Supernus Pharmaceuticals Pediatric ADHD Drugs Product Offerings
Table 76. Supernus Pharmaceuticals Pediatric ADHD Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Supernus Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Pediatric ADHD Drugs Segment by Type in 2022
Figure 2. Pediatric ADHD Drugs Segment by Application in 2022
Figure 3. Global Pediatric ADHD Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pediatric ADHD Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pediatric ADHD Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pediatric ADHD Drugs Revenue in 2022
Figure 8. By Type - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pediatric ADHD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 16. US Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 28. China Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pediatric ADHD Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pediatric ADHD Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly and Company Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Tris Pharma Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Noven Pharmaceuticals Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Alcobra Pharmaceuticals Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GlaxoSmithKline Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Purdue Pharma Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda Pharmaceutical Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Curemark Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Supernus Pharmaceuticals Pediatric ADHD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
